JMJD6 and lung carcinoma: However, apoptosis is enhanced in cisplatin (DDP)-resistant A549 (A549/DDP) cells via connecting JMJD6 per se, and it suggests MiR-106a-5p and JMJD6 as a potential biomarker in lung cancer [262] (Table 6).